This pilot study will assess the safety and feasibility of using an implantable microdevice to measure local intratumor response to chemotherapy and other clin…

Grade II GliomaGrade III GliomaGrade IV Glioma+5 more

~Estimated

~$10 – $7,500

Oliver JonasNCT04135807

Phase 1

Phase I-II Study Evaluating HSV-tK + VALACYCLOVIR GENE THERAPY Combination With Radiotherapy and Chemotherapy for Newly Diagnosed Anaplastic Astrocytoma and Glioblastoma Multiforme.

Study to assess the safety and efficacy of HSV-tk (gene therapy), valacyclovir, radiotherapy and chemotherapy in newly diagnosed glioblastoma multiforme (GBM) …

GlioblastomaAnaplastic Astrocytoma

~Estimated

~$10 – $6,250

The Methodist Hospital Research InstituteNCT03603405

Phase 2

Phase II Trial of Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory Glioblastoma Multiforme, Anaplastic Astrocytoma, and Anaplastic Oligoastrocytoma

Primary brain tumors are typically treated by surgery, radiation therapy and chemotherapy, either individually or in combination. Present therapies are inadequ…

GlioblastomaAnaplastic AstrocytomaAnaplastic Oligoastrocytoma+6 more

~Estimated

~$10 – $7,500

Northwell HealthNCT02800486

← PreviousPage 2 of 2Next →